Kiniksa Pharmaceuticals International PLC Class A KNSA
News
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution
Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024
Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease